Is Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Going to Burn These Hedge Funds?

Is Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) the right investment to pursue these days? Prominent investors are taking a bearish view. The number of long hedge fund bets were cut by 1 lately.

At the moment, there are many indicators investors can use to watch the equity markets. Two of the most under-the-radar are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top hedge fund managers can trounce the market by a healthy amount (see just how much).

Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)Just as beneficial, positive insider trading activity is another way to break down the stock market universe. There are plenty of incentives for a corporate insider to drop shares of his or her company, but only one, very clear reason why they would behave bullishly. Several empirical studies have demonstrated the impressive potential of this tactic if shareholders understand what to do (learn more here).

Now, it’s important to take a peek at the key action encompassing Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL).

How have hedgies been trading Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)?

Heading into 2013, a total of 19 of the hedge funds we track held long positions in this stock, a change of -5% from one quarter earlier. With the smart money’s positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were upping their holdings considerably.

According to our comprehensive database, Julian Baker and Felix Baker’s Baker Bros. Advisors had the biggest position in Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), worth close to $81 million, comprising 2.1% of its total 13F portfolio. Coming in second is William Leland Edwards of Palo Alto Investors, with a $44 million position; 1.1% of its 13F portfolio is allocated to the company. Remaining hedgies with similar optimism include Ken Griffin’s Citadel Investment Group, James E. Flynn’s Deerfield Management and Israel Englander’s Millennium Management.

Seeing as Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) has witnessed declining sentiment from the aggregate hedge fund industry, it’s easy to see that there lies a certain “tier” of money managers who were dropping their full holdings heading into 2013. Intriguingly, Daniel Arbess’s Xerion said goodbye to the largest stake of the “upper crust” of funds we track, comprising close to $18 million in call options. Jérôme Pfund and Michael Sjöström’s fund, Sectoral Asset Management, also dumped its stock, about $11 million worth. These transactions are intriguing to say the least, as aggregate hedge fund interest fell by 1 funds heading into 2013.

What have insiders been doing with Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)?

Insider buying is most useful when the primary stock in question has seen transactions within the past 180 days. Over the last 180-day time frame, Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) has experienced 1 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

With the results shown by the aforementioned time-tested strategies, retail investors must always keep an eye on hedge fund and insider trading activity, and Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!